ALZA CORP

ALZA CORP

ALZA Corporation was a pioneering pharmaceutical company specializing in innovative drug delivery systems, including oral, transdermal, implantable, and liposomal technologies. Founded in 1968 by Dr. Alejandro Zaffaroni, ALZA developed over 20 FDA-approved prescription products targeting physicians and patients across multiple therapeutic areas, with landmark products including the Nicoderm transdermal patch for smoking cessation and Transderm Scop for motion sickness. The company faced competitive risks from larger pharmaceutical manufacturers and the complexity of manufacturing advanced delivery systems. ALZA Corporation (CIK 4310) was acquired by Johnson & Johnson in 2001 for $10.5 billion. View ALZA's historical SEC filings on Earnings Feed to research this pharmaceutical innovator.